1) Reduce failed ultrasound exams by as much as 69% with the C5-1
 | A recent ultrasound study on technically difficult patients at six sites in North America and Europe using the C5-1 PureWave transducer has shown that this technology can have a very positive impact on your ultrasound lab. Exam times has been reduced up to 38% and studies have shown a reduction in pain and fatigue from scanning in 29% to 85% of exams. + Read more |
2) Improve early detection and characterization of breast lesions
 | Now with the push of one button, the iU22 system offers tissue aberration correction on breast transducers to compensate for speed of sound variations improving detail resolution and conspicuity of lesion details. Helping you achieve optimum diagnostic performance across the spectrum of breast architecture types— dense to fatty. + Read more |
3) Reduce ultrasound exam time by up to 50% with SmartExam
 | Introducing the new SmartExam feature, while you perform the ultrasound application, the iU22 remembers every step—all required images for the study, your annotation, body markers, mode changes, and quantification requirements. You can even incorporate 3D data sets into the protocol. + Read more |
4) Discover the advantages of volume imaging
 | Use volume imaging on the iU22 system and the ViewForum workstation to view ultrasound in the same format as CT and MR. Virtually re-scan volume data in a familiar workflow, obtain critical information not available with traditional 2D views, take additional measurements, and compare ultrasound studies with other modalities. And now, the new VL13-5 volume linear array transducer on the iU22 system allows you to review volume data for breast, thyroid, musculoskeletal, vascular, and other superficial applications, complementing our other volume transducers for abdominal, OB and GYN exams. + Read more |
5) Reach a new level of diagnosis with whole body contrast-enhanced ultrasound.*
 | A narrow footprint and new advanced pulsing technologies on the C5-1 PureWave transducer provide unmatched penetration and resolution to help you characterize tumors- even in the most difficult anatomy. Advanced XRES and tissue aberration correction technologies on the L12-5 transducer can help you characterize breast tumors earlier in their development, improving treatment planning. + Read more * Whole body ultrasound contrast agents are not approved in the U.S.A. |